GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin

Clinical trial NCT00242372 · TERMINATED

Trial details

NCT number: NCT00242372
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2004-08-01
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.